CRTPPI: Assessment of Peripheral Perfusion in the Critically Ill Patient

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT02771002
Collaborator
(none)
100
1
8.5
11.8

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate PPI as a surrogate for clinical signs of peripheral perfusion in patients in septic shock and after cardiac surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: Peripheral Perfusion index by Carescape Patientenmonitor

Detailed Description

The aim of this study is to validate PPI as a continuous, objective measurement of peripheral perfusion indicated by clinical sings of tissue perfusion in patients with septic shock. Furthermore, PPI shall be compared to the perfusion of solid organs evaluated by ultrasound of liver, kidney and gut. In a group of healthy volunteers the investigators will determine normal values in ambient temperature and after cooling of an extremity. Another group of patients after cardiac surgery, where usually a poor tissue perfusion without metabolic failure is present will serve as another "control" population in their post-surgery stabilization period. The values from healthy volunteers and cardiac surgery patients will be compared to those of patients in septic shock.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Clinical Assessment of Peripheral Perfusion by Capillary Refill Time and Peripheral Perfusion Index
Actual Study Start Date :
Jul 13, 2016
Actual Primary Completion Date :
Mar 28, 2017
Actual Study Completion Date :
Mar 28, 2017

Arms and Interventions

Arm Intervention/Treatment
septic shock patients

measurements of peripheral perfusion including capillary refill time, mottling score, temperature gradient and peripheral perfusion index hourly until normalisation of lactate sonographic assesment of perfusion of solid organs once within 24h after admission

Device: Peripheral Perfusion index by Carescape Patientenmonitor
Peripheral Perfusion index measured with pulse-oximetry by Carescape Patientenmonitor

patients rewarming after cardiac surgery

measurements of peripheral perfusion including capillary refill time, mottling score, temperature gradient and peripheral perfusion index hourly until extubation

Device: Peripheral Perfusion index by Carescape Patientenmonitor
Peripheral Perfusion index measured with pulse-oximetry by Carescape Patientenmonitor

healthy volunteers

measurements of peripheral perfusion including capillary refill time and peripheral perfusion index in ambient temperature and after cooling of extremity

Device: Peripheral Perfusion index by Carescape Patientenmonitor
Peripheral Perfusion index measured with pulse-oximetry by Carescape Patientenmonitor

Outcome Measures

Primary Outcome Measures

  1. peripheral perfusion index [measurement at ICU admission and hourly till extubation or normalization of lactate, during the hospitalization without follow-up (maximal up to 72h)]

    PPI in healthy controls, septic shock patients and patients rewarming after cardiac surgery

Secondary Outcome Measures

  1. capillary refill time [measurement at ICU admission and hourly till extubation or normalization of lactate, during the hospitalization without follow-up (maximal up to 72h)]

    CRT in healthy controls, septic shock patients and patients rewarming after cardiac surgery

Other Outcome Measures

  1. sonographic assesment of solid organ perfusion [within 24h after ICU admission and 24h after first measurement]

    solid organ perfusion measured by ultrasound

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Septic patient:
Inclusion criteria:
  • ICU admission with septic shock defined as:

  • documented infection (suspected or confirmed) AND

  • systemic mean blood pressure <65mmHg requiring any dose of vasopressor despite adequate fluid resuscitation (min. 20ml/kg crystalloids) AND

  • lactate >2mmol/l

  • Deferred consent by a relative with following informed consent by patient as documented by signatures (Appendix Informed Consent Form)

Exclusion criteria:
  • Age <18 or >80 years

  • present or suspected myocardial ischemia

  • acute pulmonary embolism

  • known liver disease - Child-Pugh -Class B or C

  • known chronic renal failure

  • known peripheral artery disease

Patient after cardiac surgery:
Inclusion criteria:
  • ICU admission after coronary artery bypass grafting or valve surgery with cardiopulmonary bypass

  • General consent with admission at the University hospital

Exclusion criteria:
  • Age <18 or >80 years

  • known peripheral artery disease

  • no or only low dose of vasopressors (<300µg/h) at ICU admission

  • present or suspected myocardial ischemia

  • acute pulmonary embolism

  • known liver disease - Child-Pugh -Class B or C

  • known chronic renal failure

Healthy volunteers:
Inclusion criteria:
  • Informed consent as documented by signature (Appendix Informed Consent Form)
Exclusion criteria:
  • Age <18 or >80 years

  • known peripheral artery disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bern University Hospital Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT02771002
Other Study ID Numbers:
  • CRTPPI 04/16
First Posted:
May 12, 2016
Last Update Posted:
Jun 22, 2017
Last Verified:
Jun 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by University Hospital Inselspital, Berne

Study Results

No Results Posted as of Jun 22, 2017